Parallax Volatility Advisers’s Achillion Pharmaceuticals ACHN Stock Holding History

Parallax Volatility Advisers’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-8,000	Closed	-$33K	–	4588
2017 Q1	$33K	Sell	8,000 -43,000	-84%	-$179K	﹤0.01%	2783
2016 Q4	$211K	Buy	51,000 +1,000	+2%	+$5.32K	﹤0.01%	1869
2016 Q3	$405K	Hold	50,000	–	–	﹤0.01%	1569
2016 Q2	$390K	Buy	+50,000	New	+$429K	﹤0.01%	1565
2015 Q3	–	Sell	-25,000	Closed	-$222K	–	4632
2015 Q2	$222K	Buy	+25,000	New	+$236K	﹤0.01%	1945
2015 Q1	–	Sell	-2,100	Closed	-$26K	–	5939
2014 Q4	$26K	Buy	+2,100	New	+$25.6K	﹤0.01%	4337

Other funds holding ACHN

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Parallax Volatility Advisers's ACHN Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of Achillion Pharmaceuticals (ACHN) in Q1 2018, closing a stake of 18,312 shares — an estimated $53K sold.

Parallax Volatility Advisers first reported a position in ACHN in Q3 2014 and held it in 2 quarters. The position peaked at $53K in Q4 2017. 127 funds tracked by Wall St. Rank hold ACHN as of Q1 2018.

Parallax Volatility Advisers reported no remaining Achillion Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
Parallax Volatility Advisers sold 18,312 Achillion Pharmaceuticals shares in Q1 2018, an estimated $53K.
Parallax Volatility Advisers first reported a position in Achillion Pharmaceuticals in Q3 2014 and held it in 2 quarters.
Parallax Volatility Advisers's Achillion Pharmaceuticals position peaked at $53K in Q4 2017.
127 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.